Introduction {#sec1}
============

Oxindoles are a nitrogen-containing heterocycle and widely found in bioactive molecules.^[@ref1]^ There are many reports on the synthesis of oxindoles,^[@ref2]^ but the exploitations of straightforward synthetic methodology to prepare oxindoles containing a variety of functionalities are still challenging and important in synthetic organic chemistry. In this context, aniline derivatives possessing acrylamide moiety are one of the most attractive substrates. Various functionalities (functional group (FG)) can be introduced to oxindoles via tandem addition C--H cyclization process ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).

![Retrosynthesis of Substituted Oxindoles](ao-2018-013973_0001){#sch1}

After the discovery of Liu's oxidative difunctionalization of alkenes in acrylamides with alkyl nitriles using Pd(OAc)~2~/PhI(OAc)~2~ catalyst system,^[@ref3]^ various reactions have been reported. For example, primary and secondary alkyl groups,^[@ref4]^ aryl and alkenyl groups,^[@ref5]^ phosphorus,^[@ref6]^ nitrogen,^[@ref7]^ sulfur,^[@ref8]^ halomethyl groups,^[@ref9]^ silicon,^[@ref10]^ carbonyl groups,^[@ref11]^ and other functional groups^[@ref12]^ can be introduced as a functional group (FG). Various FG can be employed in this reaction but the reaction with tertiary alkyl group is still challenging. Li's group has reported the reaction of acrylamides with cumene or α-bromocarbonyls as a tertiary alkyl group in the presence of Pd or Ir catalyst or oxidants.^[@ref13]^ Despite the usefulness of the reaction of acrylamides for the synthesis of substituted oxindoles, a copper-catalyzed radical reaction to synthesize oxindoles **3** from the reaction of methacrylamides **1** and α-bromocarbonyls **2** as a tertiary alkyl source under high turnover number (TON) conditions, in which a radical reaction occurs, has not yet been reported^[@ref14]^ ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).

![This Work](ao-2018-013973_0004){#sch2}

We previously reported atom-transfer radical addition followed by elimination reaction to give Heck-like olefin product (atom-transfer radical substitution (ATRS)).^[@ref15]^ Generally, copper-catalyzed atom-transfer radical reactions using alkyl halides have suffered from a large amount of catalyst loadings (10--30 mol %) to obtain reasonable product yields, which might be the limited development of this protocol for industrial processes.^[@ref16]−[@ref19]^ In this context, we have developed ATRS with high catalyst efficiency.^[@ref20]^ The reaction of styrenes and α-bromocarbonyls in the presence of amine undergoes ATRS, and TONs were reached up to 8900 with reasonable yields (\>70%). Initiators for continuous activator regeneration^[@ref21]^ or activators regenerated by electron-transfer (ARGET)^[@ref22]^ process using α,α′-azobisisobutyronitrile, 2,2′-azobis(4-methoxy-2,4-dimethylvaleronitrile) (V-70) or an inorganic reductant have been employed to lower the catalyst loadings,^[@ref23]^ but our previous protocol did not need such reductants. The next issue in this field is to accomplish higher TON in tandem *tert*-alkylation C--H cyclization process. In this report, we will describe the copper-catalyzed tertiary alkylation followed by C--H cyclization to synthesize oxindoles. From the chemical process points of view, our findings could be useful to carry out copper-catalyzed radical reactions in industrial scales.

Results and Discussion {#sec2}
======================

At the first stage of this research, we optimized the reaction conditions in the presence of 10 ppm (0.001 mol %) of the Cu catalyst ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). This reaction did not occur without an amine base, a catalyst, and a multidentate nitrogen ligand (runs 1 and 2). Although a ligand is very important for this reaction, *N*,*N*,*N*′,*N*″,*N*″-pentamethyldiethylenetriamine (PMDETA), tris\[2-(dimethylamino)ethyl\]amine (Me~6~TREN), and *N*,*N*,*N*′,*N*′-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) were not effective (runs 3, 4, and 6). Moderate yield (59%) and high TON (59 000) were obtained by using tris(2-pyridylmethyl)amine (TPMA) (run 5). Et~3~N, *i*Pr~2~NH, and Hex~3~N were used instead of *i*Pr~2~EtN (Hünig's base), but the yield was not improved (runs 7--9). To obtain more reasonable yield, we screened various reaction temperatures (runs 10 and 11) and solvents, such as toluene, 1,2-dichloroethene, AcOEt, 1,2-dimethoxyethane, and dimethylformamide, but MeCN at 100 °C was the best. When the reaction was carried out with 20 and 5 ppm of CuI, 94 and 35% of **3a** with TONs of 47 000 and 70 000 were achieved (runs 12 and 13). We also used dimethyl 2,2′-azobis(isobutyrate) (**AZO**) instead of the Cu catalyst, but no reaction occurred. This result could show that our reaction does not involve a radical chain reaction ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).

![Control Experiment](ao-2018-013973_0002){#sch3}

###### Optimization[a](#t1fn1){ref-type="table-fn"}

![](ao-2018-013973_0007){#fx1}

  run   Cu (ppm)     ligand      amine         3a (%)                                   TON
  ----- ------------ ----------- ------------- ---------------------------------------- ---------
  1     0            none        *i*Pr~2~EtN   trace                                    0
  2     10           none        *i*Pr~2~EtN   trace                                    0
  3     10           PMDETA      *i*Pr~2~EtN   4                                        4000
  4     10           Me~6~TREN   *i*Pr~2~EtN   4                                        4000
  5     10           TPMA        *i*Pr~2~EtN   59                                        59 000
  6     10           TPEN        *i*Pr~2~EtN   14                                       14 000
  7     10           TPMA        Et~3~N        13                                       13 000
  8     10           TPMA        *i*Pr~2~NH    57                                       57 000
  9     10           TPMA        Hex~3~N       27                                       27 000
  10    10 (80 °C)   TPMA        *i*Pr~2~EtN   38                                       38 000
  11    10 (60 °C)   TPMA        *i*Pr~2~EtN   12                                       12 000
  12    20           TPMA        *i*Pr~2~EtN   94(78)[b](#t1fn2){ref-type="table-fn"}   47 000
  13    5            TPMA        *i*Pr~2~EtN   35                                       70 000

All reactions were carried out at 100 °C for 20 h with 0--20 ppm (20 ppm: 0.002 mol %) CuI (5 × 10^--4^ M in MeCN), ligand (5 mol %), amine (1.5 equiv), **1a** (1.0 equiv), and **2a** (2.0 equiv) in MeCN (sealed tube). Yields were determined by ^1^H NMR analysis.

5 mmol scale.

Under optimal conditions, tandem *tert*-alkylation C--H cyclization reactions smoothly proceeded by using low catalyst loadings (20--100 ppm) ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The reaction of various α-bromoesters **1** and methacrylamide derivatives **2** to give oxindoles (**3b**--**p**) achieved TON's of up to 48 000. We have tried the reaction with 20, 50, and 100 ppm of CuI catalyst. When the reactions of methacrylamides **1** possessing an electron-donating or -withdrawing group and **2a** were carried out, electron-rich substrates **1** gave **3c**--**e** and **3h** in good yields with high TONs (up to 48 000 for **3h**). **1** possessing *p*-tolyl group gave **3b** in moderate yields. We expected that electron-rich substrates have high reactivities, and electron-poor substrates tends to decrease the reactivities, according to our previous reactions.^[@ref15]^ But methacrylamide **1** possessing fluorine atom or ester group gave **3f** and **3g** in moderate yields though the catalyst loadings were very low. The reaction of **1** possessing *m*-MeOC~6~H~4~-- group did not show good selectivity and gave the regio isomers (**3d** and **3d′**). The effects of substituents on the nitrogen of **1** were tested, and Et- or Ph group of **1** also gave the corresponding oxindoles (**3i** and **3j**) in good yields with high TONs. We next examined various combinations of substituted **1** and **2**. As a result, **2** possessing cyclic, malonate, amide structures resulted in high TONs up to 45 000 (**3k**--**p**). Overall, the catalyst loadings can be reduced to 20 ppm. In those cases, high catalyst loadings were able to increase the yields when the yields were low.

###### Substrate Scope[a](#t2fn1){ref-type="table-fn"}

![](ao-2018-013973_0005){#fx2}

All reactions were carried out at 100 °C for 20 h with 20--100 ppm CuI (5 × 10^--4^ M in MeCN), TPMA (5 mol %), *i*Pr~2~EtN (1.5 equiv), **1** (1.0 equiv), and **2** (2.0 equiv) in MeCN (sealed tube).

The rationale behind the attention given to the synthesis of oxindole **3** as a building block has been based, in part, on its potential to streamline routes toward challenging synthetic targets, including complex amine compounds ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). For example, when the reduction of **3p** with BH~3~-THF was carried out, aminated oxindole **4** was obtained in good yield. On the other hand, the reaction of **3p** in the presence of LiAlH~4~ underwent reduction followed by cyclization to afford a multicyclic compound **5** in 54% yield.

![Transformations of **3p**](ao-2018-013973_0003){#sch4}

Conclusions {#sec3}
===========

In conclusion, we discovered that the reaction of methacrylamides **1** and α-bromocarbonyls **2** underwent tandem *tert*-alkylation followed by C--H cyclization to give substituted oxindoles **3** in good yields with high TONs through Cu-catalyzed ARGET process, in which Hünig's base could improve the catalyst activity. The maximum TON was 48 000 with 96% yield. We were able to obtain TON, 70 000, but yield was not reasonable. Moreover, substituted oxindoles **3** can be transformed into amine-substituted oxindole **4** and multicyclic compound **5**, which indicated the potential usefulness of oxindoles **3** as a building block. These reactions are useful to synthesize oxindoles **3** with the minimal amounts of Cu metals. Further improvements, including our original ligand design and activator for a Cu catalyst, will be described in due course.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

All reactions were carried out under nitrogen (99.95%) atmosphere. For thin-layer chromatography analyses, precoated Kieselgel 60 F254 plates (Merck, 0.25 mm thick) were used; for column chromatography, silica gel 60 (Kanto chemical, 63--210 μm) was used. Visualization was accomplished by UV light (254 nm), ^1^H and ^13^C NMR spectra were obtained using a JEOL 500 MHz NMR spectrometer. ^1^H NMR and ^13^C NMR spectra were obtained in CDCl~3~ by using CHCl~3~ (for ^1^H, δ = 7.26 ppm) and CDCl~3~ (for ^13^C, δ = 77.16 ppm) as an internal standard. High-resolution mass analyses were obtained using a ACQUITY UPLC/time-of-flight (TOF)-mass spectrometry for electrospray ionization (ESI). Anhydrous MeCN was purchased from Kanto Chemical Co., Ltd. Other chemicals obtained from TCI, Sigma-Aldrich and Wako and copper salts obtained from Sigma-Aldrich, and Wako were used directly as supplied.

General Procedure for the Synthesis of **3a**--**p** {#sec4.2}
----------------------------------------------------

**1** (0.50 mmol), CuI (MeCN solution), TPMA (0.075 mmol, 5 mol %), and diisopropylmethylamine (0.75 mmol) were sequentially added to the dram vial equipped with a stir bar and a screw cap. MeCN (1.0 mL) and **2** (0.75 mmol) were added to a dram vial. The resulting mixture was vigorously stirred under nitrogen atmosphere (purity 99.95%) for 20 h at 100 °C. After this time, the contents of the flask were filtered through the plug of silica gel with EtOAc as an eluent and then concentrated by rotary evaporation. The crude residue was purified by flash chromatography (or gel permeation chromatography (GPC) with CHCl~3~), eluting with EtOAc/hexane to afford the product **3**.

### Ethyl 3-(1,3-Dimethyl-2-oxoindolin-3-yl)-2,2-dimethylpropanoate (**3a**) {#sec4.2.1}

White solid (122 mg, 94%); mp 86--87 °C; ^1^H NMR (CDCl~3~) δ: 0.81 (s, 3H), 1.05 (s, 3H), 1.06 (t, *J* = 7.15 Hz, 3H), 1.30 (s, 3H), 2.22 (d, *J* = 14.1 Hz, 1H), 2.53 (d, *J* = 14.1 Hz, 1H), 3.21 (s, 3H), 3.64--3.79 (m, 2H), 6.84 (d, *J* = 7.7 Hz, 1H), 7.00 (t, *J* = 7.6 Hz, 1H), 7.11 (d, *J* = 7.3 Hz, 1H), 7.24 (d, *J* = 7.5 Hz, 1H). ^13^C NMR (CDCl~3~) δ: 13.79, 22.30, 26.31, 27.73, 29.45, 41.59, 47.09, 47.28, 60.31, 108.1, 121.9, 124.5, 127.9, 132.1, 143.3, 177.3, 180.8. High-resolution mass spectrometry (HRMS) (ESI-TOF) anal. calcd for C~17~H~24~NO~3~ (M + H): 290.1756. Found: 290.1756.

### Ethyl 2,2-Dimethyl-3-(1,3,5-trimethyl-2-oxoindolin-3-yl)propanoate (**3b**) {#sec4.2.2}

Viscous oil (95 mg, 66%); IR (neat) ν 2960, 1704, 1478, 1174, 813 cm^--1^; ^1^H NMR (CDCl~3~) δ: 0.78 (s, 3H), 1.04 (s, 3H), 1.06 (t, *J* = 7.2 Hz, 3H), 1.26 (s, 3H), 2.18 (d, *J* = 14.5 Hz, 1H), 2.30 (s, 3H), 2.51 (d, *J* = 14.5 Hz, 1H), 3.17 (s, 3H), 3.67--3.72 (m, 2H), 6.71 (d, *J* = 7.9 Hz, 1H), 6.90 (s, 1H), 7.03 (d, *J* = 7.9 Hz, 1H). ^13^C NMR (CDCl~3~) δ: 13.85, 21.15, 22.06, 26.40, 27.82, 29.67, 41.58, 47.05, 47.37, 60.19, 107.88, 125.34, 128.24, 131.24, 131.99, 140.95, 177.29, 180.77. HRMS (ESI-TOF) anal. calcd for C~18~H~26~NO~3~ (M + H): 304.1913. Found: 304.1912.

### Ethyl 3-(5-Methoxy-1,3-dimethyl-2-oxoindolin-3-yl)-2,2-dimethylpropanoate (**3c**) {#sec4.2.3}

White solid (127 mg, 80%); mp: 93--94 °C; IR (neat) ν 2969, 1702, 1492, 1239, 1120, 1036 cm^--1^; ^1^H NMR (CDCl~3~) δ: 0.80 (s, 3H), 1.05 (s, 3H), 1.07 (t, *J* = 7.2 Hz, 3H), 1.28 (t, *J* = 7.2 Hz, 3H), 2.20 (d, *J* = 14.5 Hz, 1H), 2.50 (d, *J* = 14.5 Hz, 1H), 3.18 (s, 3H), 3.67--3.81 (m, 2H), 3.77 (s, 3H), 6.72--6.77 (m, 3H). ^13^C NMR (CDCl~3~) δ: 13.86, 22.12, 26.46, 27.80, 29.61, 41.62, 47.00, 47.75, 55.77, 60.34, 108.28, 111.83, 112.36, 133.37, 136.81, 155.61, 177.38, 180.46. HRMS (ESI-TOF) anal. calcd for C~18~H~26~NO~4~ (M + H): 320.1862. Found: 320.1863.

### Ethyl 3-(6-Methoxy-1,3-dimethyl-2-oxoindolin-3-yl)-2,2-dimethylpropanoate (**3d**) {#sec4.2.4}

The mixture product of **3d** and **3d′** (118 mg, 74% (**3d**/**3d′** = 1.8:1)). The pure product was obtained by GPC. White solid; mp: 77--78 °C; IR (neat) ν 2970, 1713, 1606, 1474, 1260, 1067 cm^--1^; ^1^H NMR (CDCl~3~) δ: 0.91 (s, 3H), 0.92 (s, 3H), 1.07 (t, *J* = 7.1 Hz, 3H), 1.36 (s, 3H), 2.17 (d, *J* = 14.1 Hz, 1H), 2.60 (d, *J* = 14.1 Hz, 1H), 3.17 (s, 3H), 3.63--3.70 (m, 1H), 3.75--3.81 (m, 1H), 3.83 (s, 3H), 6.50 (d, *J* = 7.8 Hz, 1H), 6.55 (d, *J* = 8.4 Hz, 1H), 7.21 (dd, *J* = 7.8 and 8.4 Hz, 1H). ^13^C NMR (CDCl~3~) δ: 13.98, 24.37, 24.62, 26.49, 27.00, 41.84, 45.62, 47.32, 55.23, 60.24, 101.53, 105.50, 118.50, 129.20, 144.45, 156.40, 176.97, 180.66. HRMS (ESI-TOF) anal. calcd for C~18~H~26~NO~4~ (M + H): 320.1862. Found: 320.1862.

### Ethyl 3-(4-Methoxy-1,3-dimethyl-2-oxoindolin-3-yl)-2,2-dimethylpropanoate (**3d′**) {#sec4.2.5}

White solid; mp: 130--131 °C; IR (neat) ν 2975, 1708, 1625, 1379, 906 cm^--1^; ^1^H NMR (CDCl~3~) δ: 0.79 (s, 3H), 1.04 (s, 3H), 1.07 (t, *J* = 7.1 Hz, 3H), 1.26 (s, 3H), 2.17 (d, *J* = 14.5 Hz, 1H), 2.50 (d, *J* = 14.5 Hz, 1H), 3.18 (s, 3H), 3.69--3.80 (m, 2H), 3.81 (s, 3H), 6.41 (d, *J* = 3.3 Hz, 1H), 6.50 (dd, *J* = 8.1 and 2.6 Hz, 1H), 6.97 (d, *J* = 8.2 Hz, 1H). ^13^C NMR (CDCl~3~) δ: 13.88, 22.20, 26.40, 27.89, 29.57, 41.60, 46.84, 47.20, 55.56, 60.40, 95.98, 105.94, 123.82, 125.15, 144.53, 160.05, 177.40, 181.45. HRMS (ESI-TOF) anal. calcd for C~18~H~26~NO~4~ (M + H): 320.1862. Found: 320.1861.

### Ethyl 3-(7-Methoxy-1,3-dimethyl-2-oxoindolin-3-yl)-2,2-dimethylpropanoate (**3e**) {#sec4.2.6}

Viscous oil (140 mg, 88%); IR (neat) ν 2972, 1705, 752 cm^--1^; ^1^H NMR (CDCl~3~) δ: 0.83 (s, 3H), 1.03 (s, 3H), 1.08 (t, *J* = 7.2 Hz, 3H), 1.26 (s, 3H), 2.20 (d, *J* = 14.3 Hz, 1H), 2.48 (d, *J* = 14.3 Hz, 1H), 3.47 (s, 3H), 3.67--3.77 (m, 2H), 3.83 (s, 3H), 6.70 (dd, *J* = 7.4 and 0.9 Hz, 1H), 6.10 (d, *J* = 8.3 and 0.8 Hz, 1H), 6.91 (d, *J* = 7.4 and 8.2 Hz, 1H). ^13^C NMR (CDCl~3~) δ: 14.15, 22.72, 28.36, 29.63, 29.94, 41.93, 47.45, 47.61, 56.24, 60.54, 111.96, 117.50, 122.63, 131.46, 134.20, 145.70, 177.49, 181.21. HRMS (ESI-TOF) anal. calcd for C~18~H~26~NO~4~ (M + H): 320.1862. Found: 320.1862.

### Ethyl 3-(7-Fluoro-1,3-dimethyl-2-oxoindolin-3-yl)-2,2-dimethylpropanoate (**3f**) {#sec4.2.7}

Viscous oil (93 mg, 61%); IR (neat) ν 2974, 1715, 1234, 776 cm^--1^; ^1^H NMR (CDCl~3~) δ: 0.84 (s, 3H), 1.05 (s, 3H), 1.09 (t, *J* = 7.3 Hz, 3H), 1.30 (s, 3H), 2.22 (d, *J* = 14.6 Hz, 1H), 2.52 (d, *J* = 14.6 Hz, 1H), 3.42 (d, *J* = 2.7 Hz, 3H), 3.66--3.79 (m, 2H), 6.87--6.98 (m, 3H). ^13^C NMR (CDCl~3~) δ: 14.13, 22.67, 28.28, 29.09, 29.13, 29.72, 41.87, 47.47, 47.90, 47.92, 60.67, 116.1 (d, *J* = 19.6 Hz), 120.6 (d, *J* = 3.2 Hz), 122.6 (d, *J* = 6.4 Hz), 130.1 (d, *J* = 18.1 Hz), 135.4 (d, *J* = 3.0 Hz), 148 (d, *J* = 243.4 Hz), 177.42, 180.59. HRMS (ESI-TOF) anal. calcd for C~17~H~23~NO~3~F (M + H): 308.1662. Found: 308.1662.

### Ethyl 3-(3-Ethoxy-2,2-dimethyl-3-oxopropyl)-1,3-dimethyl-2-oxoindoline-5-carboxylate (**3g**) {#sec4.2.8}

Viscous oil (77 mg, 43%); IR (neat) ν 2972, 1703, 1609, 1280, 1224, 1094, 772 cm^--1^; ^1^H NMR (CDCl~3~) δ: 0.80 (s, 3H), 1.05 (s, 3H), 1.12 (t, *J* = 7.2 Hz, 3H), 1.32 (s, 3H), 1.39 (t, *J* = 7.2 Hz, 3H), 2.25 (d, *J* = 14.7 Hz, 1H), 2.58 (d, *J* = 14.5 Hz, 1H), 3.24 (s, 3H), 3.72--3.76 (m, 2H), 4.36 (q, *J* = 7.1 Hz, 2H), 6.87 (d, *J* = 8.3 Hz, 1H), 7.76 (s, 1H), 8.02 (d, *J* = 9.2 Hz, 1H). ^13^C NMR (CDCl~3~) δ: 13.90, 14.52, 22.47, 26.60, 27.67, 29.44, 41.52, 46.94, 47.19, 60.44, 60.93, 107.79, 124.32, 125.42, 130.89, 131.96, 147.39, 166.51, 176.86, 181.05. HRMS (ESI-TOF) anal. calcd for C~20~H~28~NO~5~ (M + H): 362.1967. Found: 362.1969.

### Ethyl 3-(4,6-Dimethoxy-1,3-dimethyl-2-oxoindolin-3-yl)-2,2-dimethylpropanoate (**3h**) {#sec4.2.9}

Viscous oil (167 mg, 96%); IR (neat) ν 3080, 2981, 2846, 1727 cm^--1^; ^1^H NMR (CDCl~3~) δ: 0.92 (s, 3H), 0.92 (s, 3H), 1.11 (t, *J* = 7.15 Hz, 3H), 1.33 (s, 3H), 2.15 (d, *J* = 14.1 Hz, 1H), 2.53 (d, *J* = 14.1 Hz, 1H), 3.16 (s, 3H), 3.74--3.77 (m, 2H), 3.81 (s, 3H), 3.83 (s, 3H), 6.10 (d, *J* = 8.6 Hz, 2H). ^13^C NMR (CDCl~3~) δ: 13.98, 24.39, 24.88, 26.46, 26.93, 41.82, 45.84, 46.91, 55.20, 55.62, 60.29, 88.08, 92.19, 110.62, 145.00, 157.00, 161.52, 177.05, 181.30. HRMS (ESI-TOF) anal. calcd for C~19~H~28~NO~5~ (M + H): 350.1967. Found: 350.1967.

### Ethyl 3-(1-Ethyl-3-methyl-2-oxoindolin-3-yl)-2,2-dimethylpropanoate (**3i**) {#sec4.2.10}

Viscous oil (118 mg, 78%); IR (neat) ν 2973, 1706, 1610, 1354, 1128 cm^--1^; ^1^H NMR (CDCl~3~) δ: 0.82 (s, 3H), 1.05 (s, 3H), 1.05 (t, *J* = 7.3 Hz, 3H), 1.26 (t, *J* = 7.3 Hz, 3H), 1.27 (s, 3H), 2.21 (d, *J* = 4.5 Hz, 1H), 2.53 (d, *J* = 4.5 Hz, 1H), 3.63--3.87 (m, 4H), 6.85 (d, *J* = 7.8 Hz, 1H), 6.97 (dt, *J* = 0.9 and 7.5 Hz, 1H), 7.10 (dd, *J* = 1.1 and 7.3 Hz, 2H), 7.21 (dt, *J* = 1.3 and 7.8 Hz, 1H). ^13^C NMR (CDCl~3~) δ: 12.24, 13.85, 22.36, 28.12, 29.56, 34.68, 41.68, 46.80, 47.29, 60.32, 108.24, 121.68, 124.69, 127.83, 132.25, 142.36, 177.33, 180.31. HRMS (ESI-TOF) anal. calcd for C~18~H~26~NO~3~ (M + H): 304.1913. Found: 304.1913.

### Ethyl 2,2-Dimethyl-3-(3-methyl-2-oxo-1-phenylindolin-3-yl)propanoate (**3j**) {#sec4.2.11}

Viscous oil (133 mg, 73%); IR (neat) ν 3049, 2973, 1715, 861 cm^--1^; ^1^H NMR (CDCl~3~) δ: 0.99 (s, 3H), 1.07 (t, *J* = 7.3 Hz, 3H), 1.11 (s, 3H), 1.43 (s, 3H), 2.32 (d, *J* = 14.5 Hz, 1H), 2.62 (d, *J* = 14.1 Hz, 1H), 3.67--3.79 (m, 2H), 6.82 (d, *J* = 7.8 Hz, 1H), 7.03 (t, *J* = 7.0 Hz, 1H), 7.16 (d, *J* = 7.2 Hz, 2H), 7.40--7.43 (m, 3H), 7.52 (t, *J* = 7.8 Hz, 2H). ^13^C NMR (CDCl~3~) δ: 14.12, 23.01, 28.65, 29.83, 42.02, 47.58, 47.76, 60.68, 109.75, 122.63, 125.05, 126.71, 128.07, 128.26, 129.91, 132.12, 135.05, 143.48, 177.56, 180.28. HRMS (ESI-TOF) anal. calcd for C~22~H~26~NO~3~ (M + H): 352.1913. Found: 352.1916.

### Ethyl 1-((1-Ethyl-3-methyl-2-oxoindolin-3-yl)methyl)cyclobutane-1-carboxylate (**3k**) {#sec4.2.12}

Viscous oil (169 mg, 90%); IR (neat) ν 2974, 1706, 1611, 1488, 1358, 1209 cm^--1^; ^1^H NMR (CDCl~3~) δ: 1.09 (t, *J* = 7.2 Hz, 3H), 1.26 (t, *J* = 7.2 Hz, 3H), 1.31 (s, 3H), 1.66--1.75 (m, 2H), 1.92--2.05 (m, 3H), 2.08--2.17 (m, 1H), 2.46 (d, *J* = 14.1 Hz, 1H), 2.53 (d, *J* = 14.1 Hz, 1H), 3.56--3.69 (m, 3H), 3.77--3.84 (m, 1H), 6.80 (d, *J* = 7.8 Hz, 1H), 6.96 (dt, *J* = 0.8 and 7.5 Hz, 1H), 7.07 (d, *J* = 7.4 Hz, 1H), 7.21 (t, *J* = 7.7 Hz, 1H). ^13^C NMR (CDCl~3~) δ: 12.46, 13.86, 16.49, 26.23, 28.09, 34.70, 35.03, 45.82, 47.14, 47.28, 60.19, 108.09, 121.55, 124.34, 127.93, 132.32, 142.74, 176.35, 179.90. HRMS (ESI-TOF) anal. calcd for C~19~H~26~NO~3~ (M + H): 316.1913. Found: 316.1915.

### Ethyl 1-((3-Methyl-2-oxo-1-phenylindolin-3-yl)methyl)cyclobutane-1-carboxylate (**3l**) {#sec4.2.13}

Viscous oil (162 mg, 86%); IR (neat) ν 2977, 1712, 1499, 1203, 1175 cm^--1^; ^1^H NMR (CDCl~3~) δ:1.09 (t, *J* = 7.1 Hz, 3H), 1.45 (s, 3H), 1.70--1.76 (m, 2H), 1.96--2.12 (m, 3H), 2.25--2.31 (m, 1H), 2.55 (d, *J* = 4.1 Hz, 1H), 2.60 (d, *J* = 4.1 Hz, 1H), 3.58 (q, *J* = 7.2 Hz, 2H), 6.75 (dd, *J* = 1.0 and 8.6 Hz, 1H), 7.01 (dt, *J* = 0.9 and 7.6 Hz, 1H), 7.13--7.16 (m, 2H), 7.39 (t, *J* = 7.4 Hz, 1H), 7.43--7.45 (m, 2H), 7.51 (t, *J* = 7.6 Hz, 2H). ^13^C NMR (CDCl~3~) δ: 13.89, 16.58, 26.53, 28.44, 35.10, 46.32, 47.32, 47.35, 60.31, 109.33, 122.23, 124.39, 126.65, 127.93, 128.01, 129.64, 131.85, 134.76, 143.72, 176.39, 179.55. HRMS (ESI-TOF) anal. calcd for C~23~H~26~NO~3~ (M + H): 364.1913. Found: 364.1913.

### Diethyl 2-((1,3-Dimethyl-2-oxoindolin-3-yl)methyl)-2-methylmalonate (**3m**) {#sec4.2.14}

Viscous oil (111 mg, 64%); IR (neat) ν 2966, 1705, 758 cm^--1^; ^1^H NMR (CDCl~3~) δ: 1.02 (s, 3H), 1.09 (t, *J* = 7.12 Hz, 3H), 1.19 (t, *J* = 7.12 Hz, 3H), 1.36 (s, 3H), 2.72 (d, *J* = 14.8 Hz, 1H), 2.76 (d, *J* = 14.8 Hz, 1H), 3.21 (s, 3H), 3.77 (q, *J* = 7.1 Hz, 2H), 4.11--4.12 (m, 2H), 6.84 (d, *J* = 7.7 Hz, 1H), 7.00 (dt, *J* = 0.9 and 7.5 Hz, 1H), 7.10 (dd, *J* = 0.9 and 7.6 Hz, 1H), 7.24--7.27 (m, 1H). ^13^C NMR (CDCl~3~) δ: 13.89, 14.14, 19.09, 26.54, 28.16, 41.39, 46.51, 53.20, 61.33, 61.76, 108.52, 122.27, 124.34, 128.48, 132.20, 143.60, 171.60, 172.43, 180.33. HRMS (ESI-TOF) anal. calcd for C~19~H~26~NO~5~ (M + H): 348.1811. Found: 348.1811.

### Diethyl 2-((7-Methoxy-1,3-dimethyl-2-oxoindolin-3-yl)methyl)-2-methylmalonate (**3n**) {#sec4.2.15}

Viscous oil (107 mg, 57%); IR (neat) ν 2976, 1703, 1464, 1245, 1106, 1021 cm^--1^; ^1^H NMR (CDCl~3~) δ: 1.03 (s, 3H), 1.10 (t, *J* = 7.1 Hz, 3H), 1.19 (t, *J* = 7.1 Hz, 3H), 1.32 (s, 3H), 2.68 (d, *J* = 14.8 Hz, 1H), 2.76 (d, *J* = 14.8 Hz, 1H), 3.47 (s, 3H), 3.77--3.82 (m, 2H), 3.84 (s, 3H), 4.08--4.14 (m, 2H), 6.70 (dd, *J* = 0.9 and 7.5 Hz, 1H), 7.00 (dd, *J* = 0.8 and 8.4 Hz, 1H), 7.10 (dd, *J* = 8.2 and 7.4 Hz, 1H). ^13^C NMR (CDCl~3~) δ: 13.74, 13.99, 18.76, 28.26, 29.69, 41.15, 46.34, 52.99, 55.92, 61.08, 61.53, 111.78, 116.72, 122.48, 131.04, 133.57, 145.46, 171.30, 172.16, 180.24. HRMS (ESI-TOF) anal. calcd for C~20~H~28~NO~6~ (M + H): 378.1917. Found: 378.1919.

### Diethyl 2-((4,6-Dimethoxy-1,3-dimethyl-2-oxoindolin-3-yl)methyl)-2-methylmalonate (**3o**) {#sec4.2.16}

Viscous oil (148 mg, 73%); IR (neat) ν 2979, 1719, 1606, 1455, 11552, 1106, 908 cm^--1^; ^1^H NMR (CDCl~3~) δ: 1.01 (s, 3H), 1.11 (t, *J* = 7.2 Hz, 3H), 1.20 (t, *J* = 7.2 Hz, 3H), 1.39 (s, 3H), 2.58 (d, *J* = 14.5 Hz, 1H), 2.86 (d, *J* = 14.5 Hz, 1H), 3.14 (s, 3H), 3.79 (s, 3H), 3.82 (s, 3H), 3.84 (q, *J* = 7.1 Hz, 2H), 4.03--4.16 (m, 2H), 6.08 (d, *J* = 2.0 Hz, 1H), 6.09 (d, *J* = 2.0 Hz, 1H). ^13^C NMR (CDCl~3~) δ: 13.86, 13.94, 18.91, 25.06, 26.38, 39.72, 46.05, 52.97, 55.25, 55.63, 61.04, 61.33, 88.14, 92.24, 110.35, 145.05, 156.91, 161.64, 171.80, 172.18, 180.51. HRMS (ESI-TOF) anal. calcd for C~21~H~30~NO~7~ (M + H): 408.2022. Found: 408.2022.

### 3-(1,3-Dimethyl-2-oxoindolin-3-yl)-2,2-dimethyl-*N*-phenylpropanamide (**3p**) {#sec4.2.17}

White solid (151 mg, 90%); mp: 137--139 °C; IR (neat) ν 3347, 3054, 2969, 1695, 752 cm^--1^; ^1^H NMR (CDCl~3~) δ: 0.94 (s, 3H), 1.14 (s, 3H), 1.30 (s, 3H), 2.25 (d, *J* = 14.5 Hz, 1H), 2.70 (d, *J* = 14.5 Hz, 1H), 3.19 (s, 3H), 6.72 (dt, *J* = 7.5 and 1.0 Hz, 1H), 6.80 (d, *J* = 7.5 Hz, 1H), 6.81 (brs, 1H), 7.05--7.08 (m, 2H), 7.17 (d, *J* = 7.5 Hz, 1H), 7.24--7.25 (m, 4H). ^13^C NMR (CDCl~3~) δ: 22.82, 26.72, 28.24, 30.03, 42.95, 46.98, 47.82, 108.14, 120.31, 122.95, 124.39, 128.91, 138.09, 142.95, 175.56, 181.43. HRMS (ESI-TOF) anal. calcd for C~21~H~25~N~2~O~2~ (M + H): 337.1916. Found: 337.1916.

### *N*-(3-(1,3-Dimethylindolin-3-yl)-2,2-dimethylpropyl)aniline (**4**) {#sec4.2.18}

To a solution of **3p** (33.4 mg, 0.1 mmol) was added 1 M BH~3~ in tetrahydrofuran (THF, 1.0 mmol, 1.0 mL) at 0 °C. The mixture was stirred at 100 °C for 14 h and then treated with MeOH (1 mL). The organic layers were collected and dried by anhydrous Na~2~SO~4~. After concentration under reduced pressure, the crude product was purified by column chromatography to afford the title compound **4** (23.2 mg, 76%, viscous oil); IR (neat) ν 3316, 2953, 2868, 2807, 1719, 1601, 1491 cm^--1^; ^1^H NMR (CDCl~3~) δ: 1.01 (s, 6H), 1.37 (s, 3H), 1.75 (d, *J* = 14.7 Hz, 1H), 1.88 (d, *J* = 14.7 Hz, 1H), 2.74 (s, 3H), 2.85 (d, *J* = 12.1 Hz, 1H), 2.95 (d, *J* = 12.1 Hz, 1H), 3.08 (d, *J* = 8.7 Hz, 1H), 3.33 (d, *J* = 8.7 Hz, 1H), 3.61 (brs, 1H), 6.48 (d, *J* = 7.8 Hz, 1H), 6.57 (dd, *J* = 8.1 and 1.1 Hz, 2H), 6.64--6.70 (m, 2H), 6.67 (dd, *J* = 7.3 and 1.2 Hz, 1H), 7.09 (dt, *J* = 7.6 and 1.3 Hz, 1H), 7.15 (dd, *J* = 7.3 and 1.2 Hz, 2H). ^13^C NMR (CDCl~3~) δ: 27.04, 27.65, 28.46, 35.99, 36.19, 44.27, 49.76, 55.52, 69.02, 107.49, 112.83, 117.05, 117.92, 122.33, 127.79, 129.31, 139.65, 149.10. HRMS (ESI-TOF) anal. calcd for C~21~H~29~N~2~ (M + H): 309.2331. Found: 309.2331.

### 3,3,4*a*,9-Tetramethyl-1-phenyl-2,3,4,4*a*,9,9*a*-hexahydro-1*H*-pyrido\[2,3-*b*\]indole (**5**) {#sec4.2.19}

To a solution of the LiAlH~4~ (37.5 mg, 1.0 mmol) in toluene (1.0 mL) was added **3p** (33.7 mg, 0.1 mmol) at 0 °C. The mixture was stirred at 110 °C for 72 h and then treated with saturated Na~2~SO~4~ aq (2.0 mL). The organic layers were collected and dried by anhydrous Na~2~SO~4~. After concentration under reduced pressure, the crude product was purified by column chromatography to afford the title compound **5** (16.5 mg, 54%, viscous oil); IR (neat) ν 3024, 2951, 2862, 2799, 1726, 1596, 1481, 1363, 751 cm^--1^; ^1^H NMR (CDCl~3~) δ: 0.87 (s, 3H), 1.10 (s, 3H), 1.4 (d, *J* = 8.5 Hz, 2H), 1.52 (s, 3H), 2.52 (s, 3H), 3.16 (dd, *J* = 12.1 and 10.3 Hz, 2H), 4.88 (s, 1H), 6.46 (d, *J* = 7.6 Hz, 1H), 6.72 (t, *J* = 7.4 Hz, 1H), 6.79 (t, *J* = 7.4 Hz, 1H), 7.00 (t, *J* = 7.2 Hz, 3H), 7.15 (dt, *J* = 7.7 and 1.1 Hz, 1H), 7.24 (t, *J* = 8.1 Hz, 2H). ^13^C NMR (CDCl~3~) δ: 24.14, 26.77, 30.27, 30.30, 33.36, 40.64, 48.18, 52.34, 87.61, 100.50, 107.50, 116.10, 118.24, 118.47, 121.21, 127.47, 129.35, 139.51, 151.94. HRMS (ESI-TOF) anal. calcd for C~21~H~27~N~2~ (M + H): 307.2174. Found: 307.2177.
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